New year sees Abbvie, Zelgen in $1.1B T-cell engager deal
New year sees Abbvie, Zelgen in $1.1B T-cell engager deal
المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.
New year sees Abbvie, Zelgen in $1.1B T-cell engager deal
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.